Standout Papers

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients wit... 2018 2026 2020 2023 264
  1. Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia (2018)
    Piers Blombery, Mary Ann Anderson et al. Cancer Discovery

Immediate Impact

15 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Standout
Apoptosis in Cancer Biology and Therapy
2025 Standout

Works of Christoffer Flensburg being referenced

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
2018 Standout

Author Peers

Author Last Decade Papers Cites
Christoffer Flensburg 235 141 142 215 167 18 664
Spyros Skoulakis 460 8 269 135 76 10 759
Hans Skvara 265 8 39 88 31 22 743
G.B. Mills 482 114 245 17 28 19 839
Simon He 463 2 41 245 148 14 833
Heather Bendall 236 115 155 179 14 614
Michela Frenquelli 357 119 297 171 18 703
Isabel Marugán 149 145 150 174 28 584
Angela Hamblin 278 127 199 96 30 688
Antonia Rodríguez 267 65 199 278 14 583
Paul Glover 246 142 152 254 17 612

All Works

Loading papers...

Rankless by CCL
2026